The Application Notebook
Paper spray mass spectrometry (MS) allows for the direct analysis of pharmaceuticals, drugs of abuse, and other small molecules from blood, urine, and other biofluids (1,2).
Paper spray mass spectrometry (MS) allows for the direct analysis of pharmaceuticals, drugs of abuse, and other small molecules from blood, urine, and other biofluids (1,2). Described herein is the application of a Velox 360 paper spray autosampler and ion source for the direct analysis of drugs of abuse in urine samples.
Paper spray is performed by depositing the sample directly onto a porous cellulosic substrate contained within a disposable cartridge (Velox Sample Cartridge). The sample is allowed to dry, and the cartridge is inserted into the automated ion source for analysis. The Velox 360 autosampler and ion source performs all of the steps necessary to perform the analysis, including loading the cartridge, depositing extraction solvent onto the cartridge, positioning the cartridge in front of the mass spectrometer inlet, and applying the ionization voltage. Ions are generated from the sharp tip of the porous substrate contained within the cartridge. The Velox 360 paper spray system provides an automated, cost effective, and efficient method for screening DOAs using mass spectrometry with minimal sample preparation.
This application note describes the use of the Velox 360 System and high resolution mass spectrometry for rapid screening of illicit drugs and pharmaceuticals from urine samples
Anonymous urine samples from a methadone clinic were obtained from Clinitox Dx (Ontario, Canada). First, 5 µLs of urine were deposited onto the Velox sample cartridge using a pipette. The sample was allowed to dry for 30 min at room temperature or was dried in a 40° incubator for 10 min. The cartridges were then analyzed automatically using the Velox 360 coupled to a Thermo Scientific Exactive™.
A typical mass spectrum from a urine sample collected at a methadone clinic is shown in Figure 1. The intense signals from various drugs of abuse, along with creatine, are shown in the mass spectrum and are within 3 ppm of the theoretical mass-to-charge ratio. The presence of these drugs in the urine sample was further confirmed by HPLC–MS-MS (data not shown).
Figure 1: Full mass spectrum recorded using paper spray directly from a dried urine sample showing the presence of various substances including the (M+H+) ions of: creatine (m/z 114.066), methamphetamine (m/z 150.158), tramadol/desmethyl-venlafaxine (m/z 264.195), EDDP (m/z 278.189), and methadone (m/z 310.215).
This application note demonstrates the suitability of paper spray mass spectrometry for the rapid screening of illicit drugs and drug metabolites in urine, particular when used in combination with high resolution MS instrumentation. Compared to more traditional approaches, the Velox 360 offers several compelling advantages for this application, including:
1) No sample preparation. Analysis is done directly from urine.
2) Rapid analysis. Less than 2 min per sample for the entire analytical procedure (excepting time required to dry samples).
3) No carry-over. Because the analysis is done from a single use cartridge, there is no worry that high concentration samples will cause carry-over.
4) No chromatography. That means no columns to replace, no carry-over on the column, and no chromatography methods to develop.
(1) H. Wang, J. Liu., R.G. Cooks, and Z. Ouyang, Angew. Chem., Int. Ed. 49, 877–880 (2010).
(2) N.E. Manicke, Q.A. Yang, H. Wang, S. Oradu, Z. Ouyang, and R.G. Cooks, Int. J. Mass Spectrom. 300, 123–129 (2011).
Prosolia Inc.
6500 Technology Center Drive, Suite 200, Indianapolis, IN 46278
tel. +1(866) 241-0239, fax +1(317) 873-3175
Website: www.prosolia.com
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.